Spectrum Library

Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge

Mult Scler Relat Disord. 2020 Jun; 41: 102097.
Published online 2020 Apr 5. doi: 10.1016/j.msard.2020.102097

Edgar Carnero Contentti, and Jorge Correa

On March 11, 2020, the World Health Organization (WHO) declared the COrona VIrus Disease-2019 (COVID-19) as a pandemic. As of March 31, 2020, the outbreak of the COVID-19 has been confirmed in around 200 countries (World Health Organization). So far, COVID-19 has infected more than 800,000 people worldwide and caused more than 37,000 deaths. In this context, the most severely affected countries are the United States of America (USA), Italy, Spain and China. As vaccines and approved targeted drugs for treatment of the COVID-19 are still unknown, the current management of COVID-19 is supportive (World Health Organization, 2020).

Launch Dashboard


Fast Facts about NMOSD